Navigating MedTech Market Access Pathway into China

As China continues to advance its healthcare reform, understanding the evolving reimbursement and market access landscape has become critical for medical technology companies. In this webinar, APACMed China, in partnership with IQVIA, will unpack the latest developments in China’s DRG reform and payer policy evolution, exploring how these trends are reshaping pathways for medical device access and innovation.

Through expert insights and interactive member discussions, the session aims to help multinational and local MedTech stakeholders better navigate policy dynamics, optimize market access strategies, and align innovation with China’s shifting value-based healthcare priorities.